CLINICAL_TRIALS
trial_result
· 2023-10-06
Clinical Trial Update: GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer [Phase 2]
Summary
Phase 2 clinical trial update for GTx-758 in men with castration-resistant prostate cancer; study terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GTx | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2023-10-06